| 168.39 Delayed Data As of 4:00pm ET |  -1.52 / -0.89%Today’s Change | 166.30 Today|||52-Week Range 210.19 | -13.50% Year-to-Date |
| Previous close | 169.91 |
| Today’s open | 168.68 |
| Day’s range | 168.18 - 170.40 |
| Volume | 2,105,415 |
| Average volume (3 months) | 3,019,666 |
| Market cap | $103.6B |
| Earnings growth (last year) | +368.59% |
| Earnings growth (this year) | -2.46% |
| Earnings growth (next 5 years) | +5.50% |
| Revenue growth (last year) | +4.32% |
| P/E ratio | 13.4 |
| Price/Sales | 5.45 |
| Price/Book | 8.56 |
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | -0.50 | -0.75% |
| ILMNIllumina Inc | -7.04 | -2.29% |
| BIIBBiogen | +1.48 | +0.65% |
| EXASExact Sciences Corp | -0.15 | -0.16% |
| Next reporting date | July 29, 2019 |
| EPS forecast (this quarter) | $3.58 |
| Annual revenue (last year) | $23.8B |
| Annual profit (last year) | $8.4B |
| Net profit margin | 35.32% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Robert A. Bradway |
Executive Vice President- Operations Esteban Santos |
Corporate headquarters Thousand Oaks, California |
